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Abstract 
A case of gastric outlet obstruction accompanied by diffuse gastritis and gastric ulcer 
due to cytomegalovirus infection is presented. The patient, a woman aged 67 years with 
a long history of rheumatoid arthritis under immunosuppressive treatment 
(methotrexate), was admitted to our department complaining mostly of abdominal pain 
located in the epigastrium and the right abdomen. Upper gastrointestinal endoscopy 
revealed the presence of gastritis accompanied by ulcer in the prepyloric area and 
gastric outlet obstruction due to cytomegalovirus infection which was confirmed 
histologically. The patient responded well – although after many weeks – to specific 
treatment with antiviral treatment (ganciclovir). It is concluded that gastric outlet 
obstruction caused by cytomegalovirus infection can be observed in 
immunocompromised patients. The clinician must search for possible cytomegalovirus 
infection in all immunocompromised patients presenting with a clinical picture of gastric 
outlet obstruction by obtaining enough biopsies and by asking the histopathologist to 
specifically stain the specimen for the presence of cytomegalovirus, especially if 
infection by Helicobacter pylori is not present. 
 
Introduction 
Cytomegalovirus (CMV) infection is a common cause of morbidity and mortality 
among patients receiving immunosuppressive treatment. Gastrointestinal infection by  
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CMV includes mainly involvement of the large bowel, especially in patients with 
underlying inflammatory bowel disease. Gastritis caused by CMV infection in 
immunocompromised patients, although quite rare, seems to be important from both a 
clinical and therapeutic point of view [1, 2]. Moreover, diffuse gastritis due to CMV 
infection has been described in bone marrow transplant patients [3], in patients after cord 
blood transplantation for acute myeloid leukemia [4] and after rituximab treatment for 
non-Hodgkin’s lymphoma [5]. It must be stressed however that development of CMV 
gastritis and gastric ulcer has also been noticed
 in immunocompetent subjects [6, 7]. 
Gastric outlet obstruction (GOO) due to CMV infection has very rarely been described 
[8]. We present a woman with long-standing rheumatoid arthritis who developed diffuse 
gastritis accompanied by gastric ulcer and GOO due to CMV infection while receiving 
methotrexate and non-steroidal anti-inflammatory drugs for a long period of time. 
Case Report 
A woman aged 67 years was admitted to our department because of abdominal pain located mainly 
in the epigastrium and right side of the abdomen accompanied by weight loss and fatigue. The 
symptoms had appeared eight months before with a clinical episode compatible with gastroenteritis. 
Personal history included rheumatoid arthritis and the patient had been on regular treatment with 
methotrexate for more than twelve years. During the last few months she had also been receiving 
non-steroidal anti-inflammatory drugs on demand. She was a current smoker. On physical 
examination, except for some tenderness on palpation of the epigastrium and right abdomen, no 
significant findings were noticed. Initial investigations revealed low hemoglobin concentration (9.5 g/l) 
and hematocrit (31%), increased erythrocyte sedimentation rate (39 mm/1st h) and fibrinogen 
(411 mg/dl), increased CRP and a1-acid-glycoprotein (17 and 1.44 g/l, respectively) and low serum 
albumin (3 g/l). Liver and thyroid function tests were normal. Serum tumor markers, gastrin, 
vitamin B12 and folic acid were normal. Blood and stool cultures were negative. Microscopic 
examination of stool specimen was unremarkable. IgG and IgA antibodies against Yersinia enterocolitica 
[Yop M (2a)] (Western blot) were negative. Chest X-ray
 was normal. Serum IgG anti-CMV antibodies 
were positive while serum IgM anti-CMV antibodies were negative. Serum IgG and IgA levels were low. 
Antinuclear and pANCA antibodies were positive (table 1). 
A computerized tomography scan (hydro-CT) of the abdomen revealed thickening of the gastric wall 
located mainly in the antrum. Transabdominal ultrasonography revealed normal findings. Upper 
gastrointestinal endoscopy demonstrated multiple linear exudative gastric ulcers, the largest being 3 cm 
in diameter. The pylorus was edematous and narrowed. The 9 mm endoscope was finally passed 
through the pylorus, although with great difficulty. Colonoscopy performed at that time revealed some 
aphthous ulcers in the terminal ileum. 
Histology of the terminal ileum revealed only mild inflammatory infiltration and lymphoid 
hyperplasia. Histological examination of specimens obtained from the gastric ulcer, the surrounding 
area and other parts of the stomach revealed the presence of diffuse gastritis. Abundance of 
hyperchromatic epithelial cells with nuclear viral inclusions (owl’s eye) was demonstrated. These cells 
were positive for monoclonal antibodies against CMV (fig. 1). Helicobacter pylori could not be 
demonstrated in the gastric biopsies. Repeat upper gastrointestinal endoscopy performed few days later 
because of worsening of symptoms, as well as histology of gastric specimens, confirmed the previous 
results. However, this time and despite great efforts, passing the endoscope through the pylorus was 
impossible. 
Consequently, treatment with intravenous ganciclovir (2 × 5 mg/kg/day) was initiated with slow 
clinical improvement seen after 3-week treatment. However, after 6 weeks continuous treatment her 
symptoms resolved almost completely and on a subsequent endoscopy only signs of healing ulcers were 
seen. Colonoscopy performed again after 2 months was unremarkable.  
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Discussion 
The intriguing element in this case is the atypical manifestation of the patient’s disease 
state, namely GOO accompanied by severe gastric ulceration without the heralding 
symptoms of emesis, inability to eat, bloating, early satiety and epigastric fullness. The 
interest in this case is the clinical scenario in which CMV, although a common viral factor 
especially in immunocompromised patients, was not an asymptomatic bystander, but 
instead was etiologically associated with the disease. The present case obviously leads to 
the assumption that the appearance of GOO in immunocompromised patients must 
guide the physician not to proceed immediately with surgical restoration of the continuity 
of the gastrointestinal tract, but to wait for the results of the histology. After confirmation 
of diagnosis of CMV infection, the physician must also wait for the results of the specific 
antiviral treatment before considering a surgical approach. 
Our case also raised some diagnostic dilemmas because of the absence of 
pathognomonic endoscopic features for CMV infection and also created difficulties 
concerning both the right medical treatment and the best way of follow-up. The message 
for the clinical gastroenterologist is to search for the possibility of the existence of CMV 
infection in immunocompromised patients with a clinical picture compatible with GOO 
by obtaining a large number of biopsies and by asking specifically for CMV staining, 
especially if infection by Helicobacter pylori is not present. 
An important point regarding the diagnosis and course of CMV infection could be the 
number of infected cells in the biopsy specimens in relation to the severity of endoscopic 
lesions. In a relevant study, no correlation between CMV inclusion bodies count and 
severity of symptoms or length of survival could be demonstrated [9]. On the other hand, 
coexistence of other potential pathogens, such as herpes simplex, mycobacteria and 
candida, could – at least theoretically – further complicate the clinical course [9]. The 
coexistence of other infective agents was excluded by clinical and laboratory findings 
(normal chest X-ray, negative Mantoux test) as well as special staining of biopsy 
specimens (Ziel Nielsen-PAS). 
Another interesting point in this case was the negative serum IgM anti-CMV 
antibodies despite the presence of CMV in the gastric biopsies. However, it is generally 
accepted that in patients with active CMV infection, negative serologic test can be 
obtained as this test is an unreliable marker of diagnosis of current infection due to low 
sensitivity [10]. 
CMV gastritis may appear in non-immunosuppressed individuals as well. Vergara et 
al. [6] described two immunocompetent patients with gastric ulcer as the only 
manifestation of CMV infection. Both patients required antiviral treatment, and one case 
evolved to GOO requiring surgery. The latter case, as well as the case described by 
Mohammed et al. [8] and our own, are probably the only cases of CMV gastritis 
accompanied by GOO described so far in the literature. 
Some descriptions suggest that the clinical picture of CMV gastritis is dominated by 
epigastric pain having some special characteristics: it is decreasing in supine position of 
the patient and it is increasing while sitting, standing or walking [2]. In our patient the 
cardinal symptom was also abdominal pain mainly located in the epigastrium and having 
the same characteristics as those described in the literature. 
Diagnosis of CMV gastritis can be very difficult if one relies only on the findings of 
upper gastrointestinal endoscopy as the endoscopic picture is not characteristic [11]. The 
protean radiologic features are not specific either and may mimic several other conditions  
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[12]. It has been suggested that diagnosis of CMV gastritis can be facilitated by the use of 
qualitative PCR. However, we suggest that clinical suspicion plays the most important 
role in making the correct diagnosis. The clinician should always consider CMV infection 
as a possible cause of gastritis, especially in immunosuppressed patients. Consequently, 
the endoscopist must advise the histopathologist accordingly in order to search for the 
presence of CMV infection. 
Data concerning the natural history of CMV gastritis are not available. The 
pathophysiological consequences of CMV gastritis are not well understood either, 
although reduced gastric emptying [13] and dysmotility
 [14] have been described. In all 
cases of CMV gastritis described so far, epigastric pain completely resolved after 
treatment with ganciclovir [1], as it happened in our patient. Prolonged low-dose 
ganciclovir prophylaxis after heart transplantation reduces the incidence of CMV disease 
in CMV-mismatched patients and reduces the morbidity of CMV disease in 
CMV-positive recipients [15]. 
We cannot answer the question whether the aphthous ulcers seen in the terminal ileum 
in the first colonoscopy were actually part of a disseminated CMV infection or the result 
of the consumption of NSAIDs. Histology did not confirm the presence of CMV 
infection. However, the disappearance of the lesions in the follow-up colonoscopy after 
completion of anti-CMV treatment might be a clue to CMV ileitis. 
Conclusion 
GOO caused by CMV infection can be noticed in immunocompromised patients. The 
clinician must search for the presence of CMV infection in all immunocompromised 
patients presenting with a clinical picture of GOO by obtaining enough biopsies and by 
asking the histopathologist to specifically stain the specimen for CMV infection, 
especially if infection by Helicobacter pylori is not present. 
 
 
 
Table 1. Results of serum immunological parameters 
Parameter Initial  value 
ANA  positive in low titer 
RA test  negative 
Serum immunoglobulins  low IgG and IgA 
Immunoblotting  absence of paraprotein 
pANCA positive 
IgG CMV (serum)  positive (32) 
[positive >11 AU/ml] 
IgM CMV (serum)  negative (1.13) 
[positive >11 AU/ml] 
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Fig. 1. Gastric epithelium CMV(+), 60×. Immunohistochemistry with monoclonal anti-CMV 
(CMV Ab1, clone 01). 
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